CET Has Been Rewarded A Sole Source Navy Contract for Human Amniotic Mesenchymal Stem Cells.

 

November 3, 2017

 

CET announces that they are the recipient of a sole source navy contract for providing human amniotic mesenchymal stem cells.  Terms of the contract are not disclosed.  According to the contract, CET won a sole source military contract because its mesenchymal performed superior to other vendor's mesenchymal stem cells.